C19 DEVELOPMENT Trademark

Trademark Overview

On Tuesday, April 21, 2020, a trademark application was filed for C19 DEVELOPMENT with the United States Patent and Trademark Office. The USPTO has given the C19 DEVELOPMENT trademark a serial number of 88880539. The federal status of this trademark filing is REGISTERED as of Tuesday, September 14, 2021. This trademark is owned by NOWDiagnostics, Inc.. The C19 DEVELOPMENT trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Diagnostic services, namely, medical diagnostic testing for human autoimmune and infectious diseases and COVID-19 with kits
c19 development

General Information

Serial Number88880539
Word MarkC19 DEVELOPMENT
Filing DateTuesday, April 21, 2020
Status700 - REGISTERED
Status DateTuesday, September 14, 2021
Registration Number6488323
Registration DateTuesday, September 14, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Disclaimer with Predetermined Text"C19"
Goods and ServicesDiagnostic services, namely, medical diagnostic testing for human autoimmune and infectious diseases and COVID-19 with kits

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 30, 2020
Primary Code044
First Use Anywhere DateFriday, May 22, 2020
First Use In Commerce DateFriday, May 22, 2020

Trademark Owner History

Party NameNOWDiagnostics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSpringdale, AR 72764
Party NameNOWDiagnostics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSpringdale, AR 72764

Trademark Events

Event DateEvent Description
Tuesday, September 14, 2021REGISTERED-SUPPLEMENTAL REGISTER
Friday, August 6, 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 6, 2021ASSIGNED TO LIE
Thursday, August 5, 2021APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Monday, August 2, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 2, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 2, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 27, 2021NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Monday, April 26, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 26, 2021NON-FINAL ACTION E-MAILED
Monday, April 26, 2021NON-FINAL ACTION WRITTEN
Monday, April 26, 2021USE AMENDMENT ACCEPTED
Wednesday, April 21, 2021AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, April 21, 2021USE AMENDMENT FILED
Tuesday, April 20, 2021TEAS AMENDMENT OF USE RECEIVED
Tuesday, April 20, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 20, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 20, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 22, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 22, 2020NON-FINAL ACTION E-MAILED
Thursday, October 22, 2020NON-FINAL ACTION WRITTEN
Monday, October 19, 2020ASSIGNED TO EXAMINER
Thursday, April 30, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, April 24, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

development diagnostic infectious diseases covid kits autoimmune human services namely medical